Rare diseases
Investigational molecules
Locations
Back to Italy1 011 clinical trials in Arezzo, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Pembrolizumab for Patients with Resectable Metastases from Kidney Cancer
ItalyStudy of CLN-081 tablets in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations who have previously received platinum chemotherapy
ItalyStudy of Efgartigimod for Adults with Thyroid Eye Disease
ItalyStudy on INZ-701 for Improving Survival in Infants with ENPP1 Deficiency
ItalyStudy of N-Acetyl-GED-0507-34-LEVO gel 5% applied daily for treating acne vulgaris
ItalyStudy on the Effectiveness and Safety of Osimertinib for Patients with Early-Stage Non-Small Cell Lung Cancer After Tumor Removal
ItalyStudy on the Effects of Obexelimab for Patients with Relapsing Multiple Sclerosis
ItalyStudy on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
ItalyStudy Comparing Bomedemstat and Hydroxycarbamide for Patients with Essential Thrombocythemia
ItalyStudy on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
ItalyStudy on the Safety and Effectiveness of Etrumadenant, Quemliclustat, and Zimberelimab in Patients with Metastatic Colorectal Cancer
ItalyStudy on Chlorambucil and Rituximab for Patients with MALT Lymphoma
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on bladder cancer treatments, including innovative therapies combining immunotherapy with established treatments. Studies evaluate new approaches for both muscle-invasive and non-muscle invasive disease.
Multiple trials exploring targeted treatments for patients with various stages of disease progression.
Advanced studies examining new therapeutic approaches for metastatic prostate cancer, including novel drug combinations and targeted therapies for specific genetic mutations.
Investigating innovative treatment sequences and combinations to improve patient outcomes.
Cutting-edge research in renal cell carcinoma treatment, exploring immunotherapy combinations and targeted approaches for both early-stage and metastatic disease.
Focus on improving survival rates through novel therapeutic strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
